Temporal phenotyping for transitional disease progress: An application to epilepsy and Alzheimer's disease

Complicated multifactorial diseases deteriorate from one disease to other diseases. For example, existing studies consider Alzheimer's disease (AD) a comorbidity of epilepsy, but also recognize epilepsy to occur more frequently in patients with AD than those without. It is important to understand the progress of disease that deteriorates to severe diseases. To this end, we develop a transitional phenotyping method based on both longitudinal and cross-sectional relationships between diseases and/or medications. For a cross-sectional approach, we utilized a skip-gram model to represent co-occurred disease or medication. For a longitudinal approach, we represented each patient as a transition probability between medical events and used supervised tensor factorization to decompose into groups of medical events that develop together. Then we harmonized both information to derive high-risk transitional patterns. We applied our method to disease progress from epilepsy to AD. An epilepsy-AD cohort of 600,000 patients were extracted from Cerner Health Facts data. Our experimental results suggested a causal relationship between epilepsy and later onset of AD, and also identified five epilepsy subgroups with distinct phenotypic patterns leading to AD. While such findings are preliminary, the proposed method combining representation learning with tensor factorization seems to be an effective approach for risk factor analysis.

[1]  Hui Xiong,et al.  Temporal Phenotyping from Longitudinal Electronic Health Records: A Graph Based Framework , 2015, KDD.

[2]  Vadym Gnatkovsky,et al.  Potassium dynamics and seizures: Why is potassium ictogenic? , 2018, Epilepsy Research.

[3]  Peter P. Zandi,et al.  Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study , 2014, Neurobiology of Aging.

[4]  Benjamin C. M. Fung,et al.  Learning Phenotypes and Dynamic Patient Representations via RNN Regularized Collective Non-Negative Tensor Factorization , 2019, AAAI.

[5]  Scott Rickard,et al.  Comparing measures of sparsity , 2008 .

[6]  L. Volicer,et al.  Effect of seizures on progression of dementia of the Alzheimer type. , 1995, Dementia.

[7]  H. A. Born,et al.  Seizures in Alzheimer’s disease , 2015, Neuroscience.

[8]  Maria Thom,et al.  Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study. , 2011, Brain : a journal of neurology.

[9]  Hwanjo Yu,et al.  Discriminative and Distinct Phenotyping by Constrained Tensor Factorization , 2017, Scientific Reports.

[10]  Masud Husain,et al.  Cognition and dementia in older patients with epilepsy , 2018, Brain : a journal of neurology.

[11]  Laurie A. Miller,et al.  Senile plaques in temporal lobe epilepsy , 1994, Acta Neuropathologica.

[12]  Qiang Liu,et al.  Lipid metabolism in Alzheimer’s disease , 2013, Neuroscience Bulletin.

[13]  Jiajia Li,et al.  The influence of potassium concentration on epileptic seizures in a coupled neuronal model in the hippocampus , 2016, Cognitive Neurodynamics.

[14]  Jimeng Sun,et al.  Marble: high-throughput phenotyping from electronic health records via sparse nonnegative tensor factorization , 2014, KDD.

[15]  Heidi E Kirsch,et al.  Seizures and epileptiform activity in the early stages of Alzheimer disease. , 2013, JAMA neurology.

[16]  W. Marktl,et al.  Lipid metabolism in the potassium deficient rat , 2004, Pflügers Archiv.

[17]  W. Hauser,et al.  Seizures and myoclonus in patients with Alzheimer's disease , 1986, Neurology.

[18]  Daniel Friedman,et al.  Seizures and Epilepsy in Alzheimer's Disease , 2012, CNS neuroscience & therapeutics.

[19]  Xiaoqian Jiang,et al.  Multimodal Phenotyping of Alzheimer’s Disease with Longitudinal Magnetic Resonance Imaging and Cognitive Function Data , 2020, Scientific Reports.

[20]  Jimeng Sun,et al.  Granite: Diversified, Sparse Tensor Factorization for Electronic Health Record-Based Phenotyping , 2017, 2017 IEEE International Conference on Healthcare Informatics (ICHI).

[21]  R. Maganti,et al.  Neurotoxic effects associated with antibiotic use: management considerations. , 2011, British journal of clinical pharmacology.

[22]  J. Chang,et al.  Analysis of individual differences in multidimensional scaling via an n-way generalization of “Eckart-Young” decomposition , 1970 .

[23]  A Hofman,et al.  Clinical features and mortality in patients with early-onset Alzheimer's disease. , 1996, European neurology.

[24]  Mark Goadrich,et al.  The relationship between Precision-Recall and ROC curves , 2006, ICML.